On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Egypt: A recent randomized controlled trial has demonstrated that sitagliptin, a DPP-4 inhibitor, significantly improves ...

Like its peers, the impact of the present geopolitical situation may have curbed fiscal second-quarter profits for Medtronic.

About a year ago, renal denervation procedures won a huge victory after finally being greenlit by FDA. Now two of the frontrunners in the space have received reimbursement.

Medtronic and Recor Medical each announced separate Medicare reimbursement approvals for their respective renal denervation ...

Baxter will share an update on Hurricane Helene’s impact, while Medtronic will likely discuss a new pulsed field ablation ...

Roots Community Health has sued 12 other firms, including GE Healthcare, CVS and Walgreens, and called for manufacturers and ...

Defensive industries, like healthcare, are more attractive to income investors. That's because companies in this sector are ...

Luxembourg's Ministry of Health and Social Security has reported that a safety notice regarding certain models... }} ...

Medtronic reports Q3 (fiscal Q2) earnings on 11/19. The revenue estimate is $8.28 billion, while the EPS GAAP estimate is $0.94. Investors should pay particular attention to how the MiniMed recall ...

Medtronic MDT underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of their recent ...

The FDA recently announced critical recalls on several widely used medical devices, including Life2000 ventilators, Medtronic's MiniMed insulin pumps and Boston Scientific's Obsidio conformable ...